In this episode of The Oncology Journal Club, the team weigh promising trial signals against the level of evidence needed to change clinical practice. From perioperative cholangiocarcinoma to molecular matching and chrono-oncology, the focus stays on a key question: what meaningfully improves outcomes for patients?
What’s covered
NeoGOLP trial in high-risk resectable iCCA: improved event-free survival; overall survival still immature
MoST programme: molecular matching and survival associations when therapies align with biomarkers
Genomic therapy matching in clinical decision-making
Chrono-oncology: does treatment timing influence outcomes?
CHOPIN phase II uveal melanoma trial: combination therapy signals and feasibility
ASCO living guideline updates across lung, gastro-oesophageal and thyroid cancers
The Oncology Journal Club Podcast hosted by Professor Craig Underhill, Dr Kate Clarke and Professor Chris Jackson, and proudly produced by The Oncology Network
Visit oncologynetwork.com.au for Show Notes, to send us Voice Notes and more information.
Podden och tillhörande omslagsbild på den här sidan tillhör
The Oncology Network. Innehållet i podden är skapat av The Oncology Network och inte av,
eller tillsammans med, Poddtoppen.
